Diamond Biofund Valuation
Is 6901 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 6901 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 6901's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 6901's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 6901?
Key metric: As 6901 is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.
| What is 6901's PB Ratio? | |
|---|---|
| PB Ratio | 2.4x |
| Book | NT$11.13b |
| Market Cap | NT$27.04b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | -15x |
| Enterprise Value/EBITDA | -13.6x |
| PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does 6901's PB Ratio compare to its peers?
| Company | Forward PB | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 1.4x | ||
7777 ABICO Asia Capital | 1.8x | n/a | NT$3.2b |
6023 Yuanta Futures | 1.7x | n/a | NT$26.1b |
2820 China Bills Finance | 0.8x | n/a | NT$20.1b |
2855 President Securities | 1.1x | n/a | NT$39.2b |
6901 Diamond Biofund | 2.4x | n/a | NT$27.0b |
Price-To-Book vs Peers: 6901 is expensive based on its Price-To-Book Ratio (2.4x) compared to the peer average (1.4x).
Price to Book Ratio vs Industry
How does 6901's PB Ratio compare vs other companies in the Asian Capital Markets Industry?
| 46 Companies | Price / Book | Estimated Growth | Market Cap |
|---|---|---|---|
| 46 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Book vs Industry: 6901 is expensive based on its Price-To-Book Ratio (2.4x) compared to the Asian Capital Markets industry average (1.1x).
Price to Book Ratio vs Fair Ratio
What is 6901's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PB Ratio | 2.4x |
| Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate 6901's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Concord Securities
NT$8.6b
Through its subsidiaries, provides brokerage and wealth management services in Taiwan.
6016
NT$13.85
7D
-1.1%
1Y
13.2%
Reliance SecuritiesLtd
NT$1.5b
Provides professional investment services in Taiwan.
6027
NT$9.53
7D
3.1%
1Y
19.4%
Capital Securities
NT$47.5b
Provides various financial services in Taiwan and internationally.
6005
NT$21.90
7D
-1.6%
1Y
44.1%